AR122228A1 - Composiciones de spray nasal antiviral y viricida y métodos de tratamiento relacionados - Google Patents
Composiciones de spray nasal antiviral y viricida y métodos de tratamiento relacionadosInfo
- Publication number
- AR122228A1 AR122228A1 ARP210101073A ARP210101073A AR122228A1 AR 122228 A1 AR122228 A1 AR 122228A1 AR P210101073 A ARP210101073 A AR P210101073A AR P210101073 A ARP210101073 A AR P210101073A AR 122228 A1 AR122228 A1 AR 122228A1
- Authority
- AR
- Argentina
- Prior art keywords
- approximately
- mass
- concentration
- composition
- nasal spray
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Composiciones de spray nasal antiviral y viricida para el tratamiento o prevención de infecciones virales, tales como influenza A y B, coronavirus, incluyendo sin carácter taxativo, COVID-19, y rinovirus, junto con métodos de tratamiento relacionados. Ciertas composiciones de acuerdo con realizaciones preferentes de la invención pueden comprender clorfeniramina, xilitol y otros ingredientes inactivos tales como aloe vera y/o extracto de semillas de uva. Asimismo, las composiciones pueden comprender un corticosteroide seleccionado del grupo conformado por mometasona, propionato de fluticasona, furoato de fluticasona, acetónido de triamcinolona y/o glucocorticoide budesónida, en una concentración de entre 0,01% y 3% aproximadamente por masa. Los métodos de tratamiento relacionados comprenden la administración de una composición del spray nasal dentro de los conductos nasales del paciente mediante 1 a 2 pulverizaciones de la composición cada seis, ocho o doce horas. Reivindicación 1: Una composición de spray nasal antiviral y viricida, caracterizada porque comprende: A) maleato de clorfeniramina en una concentración de entre 0,01% y 10% aproximadamente por masa; B) xilitol en una concentración de entre 10% y 15% aproximadamente por masa; y C) extracto de semillas de uva en una concentración de entre 0,01% y 3% aproximadamente por masa; estando dicho maleato de clorfeniramina en una concentración de entre 0,25% y 4% aproximadamente por masa; comprendiendo dicha composición un corticosteroide seleccionado del grupo conformado por mometasona, propionato de fluticasona, furoato de fluticasona, acetónido de triamcinolona y/o glucocorticoide budesónida, en una concentración de entre 0,01% y 3% aproximadamente por masa; siendo dicho corticosteroide preferentemente propionato de fluticasona en una concentración de entre 0,03% y 1,0% aproximadamente por masa; siendo dicha composición utilizada en el tratamiento de infecciones virales seleccionadas a partir del grupo conformado por resfríos, influenza A y B, coronavirus, especialmente COVID-19 y rinovirus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063015415P | 2020-04-24 | 2020-04-24 | |
US16/924,683 US10874650B1 (en) | 2020-04-24 | 2020-07-09 | Antiviral and virucidal nasal spray compositions and related treatment methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AR122228A1 true AR122228A1 (es) | 2022-08-31 |
Family
ID=74039572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210101073A AR122228A1 (es) | 2020-04-24 | 2021-04-21 | Composiciones de spray nasal antiviral y viricida y métodos de tratamiento relacionados |
Country Status (9)
Country | Link |
---|---|
US (1) | US10874650B1 (es) |
EP (1) | EP3993788A4 (es) |
CN (1) | CN115605203A (es) |
AR (1) | AR122228A1 (es) |
AU (1) | AU2020443548B2 (es) |
BR (1) | BR112022021556A2 (es) |
CA (1) | CA3176035C (es) |
MX (1) | MX2022013169A (es) |
WO (1) | WO2021216118A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11426392B1 (en) * | 2021-04-14 | 2022-08-30 | Ferrer Medical Innovations, Llc. | Antiviral and virucidal lung nebulizer compositions and related treatment methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3153797A (en) * | 1996-06-04 | 1998-01-05 | Procter & Gamble Company, The | A nasal spray containing an intranasal steroid and an antihistamine |
US6054143A (en) * | 1998-03-24 | 2000-04-25 | Jones; Alonzo H. | Xylitol delivery |
US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
AU2006226887A1 (en) * | 2005-03-23 | 2006-09-28 | Elan Pharma International Limited | Nanoparticulate corticosteroid and antihistamine formulations |
US20080058421A1 (en) * | 2006-09-05 | 2008-03-06 | John Alex Lopes | Compositions for cleaning and disinfecting nasal tract and sinus cavity |
CN103239446B (zh) * | 2013-05-13 | 2014-11-12 | 中国科学院武汉病毒研究所 | 一种马来酸氯苯那敏在制备治疗或预防流感病毒药物中的应用 |
EP3965886A4 (en) * | 2019-02-15 | 2023-06-07 | Ferrer Medical Innovations, LLC | NASAL SPRAY COMPOSITIONS AND RELATED METHODS OF TREATMENT |
-
2020
- 2020-07-09 US US16/924,683 patent/US10874650B1/en active Active
- 2020-11-16 CN CN202080096130.3A patent/CN115605203A/zh active Pending
- 2020-11-16 BR BR112022021556A patent/BR112022021556A2/pt not_active Application Discontinuation
- 2020-11-16 MX MX2022013169A patent/MX2022013169A/es unknown
- 2020-11-16 EP EP20932020.9A patent/EP3993788A4/en active Pending
- 2020-11-16 AU AU2020443548A patent/AU2020443548B2/en active Active
- 2020-11-16 WO PCT/US2020/060732 patent/WO2021216118A1/en unknown
- 2020-11-16 CA CA3176035A patent/CA3176035C/en active Active
-
2021
- 2021-04-21 AR ARP210101073A patent/AR122228A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3993788A4 (en) | 2023-08-02 |
AU2020443548B2 (en) | 2023-03-16 |
US10874650B1 (en) | 2020-12-29 |
WO2021216118A1 (en) | 2021-10-28 |
BR112022021556A2 (pt) | 2022-12-06 |
CN115605203A (zh) | 2023-01-13 |
CA3176035C (en) | 2023-09-12 |
EP3993788A1 (en) | 2022-05-11 |
CA3176035A1 (en) | 2021-10-28 |
AU2020443548A1 (en) | 2022-11-10 |
MX2022013169A (es) | 2022-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20201506T1 (hr) | Uporaba kanabidiolne kiseline u liječenju epilepsije | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
PH12018502091A1 (en) | Preventive and curative peroxometallate based composition, notably pharmaceutical composition | |
US20100086626A1 (en) | Capsaicinoid decontamination compositions and methods of use | |
AR122228A1 (es) | Composiciones de spray nasal antiviral y viricida y métodos de tratamiento relacionados | |
CL2023000998A1 (es) | Formulación farmacéutica para inhalador presurizado de dosis medidas | |
RU2011122513A (ru) | Композиция для профилактики и лечения вирусных инфекций | |
PE20011271A1 (es) | Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares | |
US20240180885A1 (en) | Composition and delivery method for treatment of pharyngeal tonsil | |
CO2023011781A2 (es) | Formas de dosificación farmacéuticas que comprenden (4s)–24–cloro–4–etil–73–fluoro–35–metoxi–32,5–dioxo–14–(trifluorometil)–32h–6–aza–3(4,1)–piridina–1(1)–[1,2,3]triazola–2(1,2),7(1)–dibencenaheptafano–74–carboxamida | |
WO2012019204A2 (en) | Therapeutic agent for intranasal administration and method of making and using same | |
JP2014515360A (ja) | フルチカゾンを含む鼻用医薬製剤 | |
FR3064180B1 (fr) | Formulations comprenant des actifs issus de la plante murraya koenigii | |
US9301988B2 (en) | Method of treatment using a therapeutic agent for intranasal administration | |
WO2020168289A1 (en) | Nasal spray compositions and related treatment methods | |
AU2021106876A4 (en) | Formulations comprising botanical extracts | |
US20130115321A1 (en) | Therapeutic agent for intranasal administration and method of making and using same | |
RU2780378C1 (ru) | Композиции назального спрея и связанные способы лечения | |
CA3178758A1 (en) | Treatment of adjustment disorders | |
KR20230113318A (ko) | 저용량 정유를 기반으로 하는 신규한 치료용 조성물 | |
WO2023144614A1 (en) | Nasal compositions and methods thereof | |
TR201716233A2 (tr) | Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim. | |
RU2022104691A (ru) | Ингибиторы моноаминоксидазы в для применения в предупреждении или лечении карциномы предстательной железы | |
WO2016099233A3 (ru) | Фармацевтическая композиция для лечения туберкулеза |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |